U.S. MicroRNA Market (2024 - 2030) Size, Share & Trends Analysis Report By Products & Services, By Application (Cancer, Infectious Diseases), By End-use (Biotechnology & Pharmaceutical Companies), And Segment Forecasts

Market Segmentation

U.S. MicroRNA Products & Services Outlook (Revenue, USD Million, 2018 - 2030)
- Services
  - Type
    - Isolation & Purification
    - miRNA cDNA Synthesis
    - Profiling, Localization, & Quantification
    - Functional Analysis
    - Others
  - Specimen
    - Whole Blood
    - Serum
    - Plasma
    - FFPE
    - Fresh Frozen Tissue
    - Others
- Products
  - Instruments
    - Technology
      - Real Time PCR
      - Microarray
      - NGS
      - Others
    - Workflow
      - Isolation & Purification
      - miRNA cDNA Synthesis
      - Profiling, Localization, & Quantification
      - Functional Analysis & Others
      - Others
  - Consumables
    - Specimens
      - Whole Blood
      - Serum
      - Plasma
      - FFPE
      - Fresh Frozen Tissue
      - Others
    - Workflow
      - Isolation & Purification
      - miRNA cDNA Synthesis
      - Profiling, Localization, & Quantification
      - Functional Analysis
      - Others
U.S. MicroRNA Application Outlook (Revenue, USD Million, 2018 - 2030)
- Cancer
- Infectious Diseases
- Immunological Disorder
- Cardiovascular Disease
- Neurological Disease
- Others
U.S. MicroRNA End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Biotechnology & Pharmaceutical Companies
- Academic & Government Research Institutes
- Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments